SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ADMA - http://www.admabiologics.com/
ADMA 19.53+0.2%12:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Leo Fisher9/21/2017 11:12:13 PM
  Read Replies (1) of 3
 
For those interested please be aware of the timeline for BLA re-submission (2018-2019).

Excerpts from ADMA SEP 2017 Investor Update found at ir.admabiologics.com are below

  • Our top priority is to remediate the outstanding compliance issues identified at out acquired manufacturing facility and ensure that the status of the previously issued FDA Warning Letter is lifted and the objectionable status is eliminated


  • Our goal with respect to this remediation project is to be “inspection ready” in approximately 6 months


  • We anticipate that we will be in a position to refile the Biologics License Application (“BLA”) for RI-002 in the middle of 2018
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext